PAPER Royall DR, Palmer R, Chiodo LK, Polk MJ
SEARCH RESULTS
329963 RESULTS
PAPER Mohamed A, Cortez L, de Chaves EP
Aggregation state and neurotoxic properties of alzheimer β-amyloid peptide.
Curr Protein Pept Sci. 2011 May 1;12(3):235-57. PubMed: 21348837PAPER Pritchard SM, Dolan PJ, Vitkus A, Johnson GV
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics.
J Cell Mol Med. 2011 Aug;15(8):1621-35. PubMed: 21348938PAPER Bonda DJ, Lee HG, Camins A, Pallàs M, Casadesus G, Smith MA, Zhu X
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.
Lancet Neurol. 2011 Mar;10(3):275-9. PubMed: 21349442PAPER Texidó L, Martín-Satué M, Alberdi E, Solsona C, Matute C
Amyloid β peptide oligomers directly activate NMDA receptors.
Cell Calcium. 2011 Mar;49(3):184-90. PubMed: 21349580PAPER Liu Y, Lee SY, Neely E, Nandar W, Moyo M, Simmons Z, Connor JR
Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.
J Biol Chem. 2011 Apr 15;286(15):13161-70. PubMed: 21349849PAPER Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, De Ceballos ML
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.
Mol Pharmacol. 2011 Jun;79(6):964-73. PubMed: 21350020PAPER Vishal S, Sourabh A, Harkirat S